News in English
Enter any phrase or word you would like to search for and click .
PostNews: Press Release
PHI achieves market acceptance goals
Prior to the company’s IPO in early 2014, three market acceptance goals were set out to be achieved by the end of 2015: 50 units in operation at customers and key opinion leaders, collaboration agreements with 8 key opinion leaders and the company’s main product HoloMonitor® M4 shall be manufactured in series production.
Learn more …
PostPress Release
PHI invited to speak at world leading scientific event
Learn more …
PostNews: Press Release
Big Pharma embraces HoloMonitor technology from PHI
Upon completion of an extensive evaluation in early September one of the top pharmaceutical companies in the world has decided to acquire two HoloMonitor® instruments. The ordered configuration is an automated version of the HoloMonitor platform.
Learn more …
PostNews: Press Release
HoloMonitor technology help researchers fight ovarian cance
Ovarian cancer is one of the deadliest forms of cancer. Researchers at the Center of Excellence for Holographic Imaging at Northeastern University in Boston have used HoloMonitor technology to study how the immune system can be stimulated to fight this deadly cancer form. The research results have been published in Journal of Clinical & Cellular Immunology.
Learn more …
PostPress Release
Phase Holographic Imaging receives first order from United Kingdom after exhibition
Learn more …
PostNews
Florida International University and PHI collaborate to fight cancer
Learn more …